Precision molecular diagnostic techniques: diagnostic applications for influenza and dengue viruses
The change of season serves as a high prevalence point for influenza viruses, launching a new round of challenges to our immune systems.
These viruses have been a hot public health concern, and there has been a lot of concern about protective measures, and how to quickly diagnose whether or not you are infected, treat it in a timely manner, and cut off the means of transmission.
Influenza A and Influenza B
Recently, under the influence of cold air in the north, influenza A and B are frequent, as they are usually more active in the fall and winter seasons, lasting from the fall of each year to the spring of the following year.
At present, the main epidemics for the A H1N1 and H3N2, children and the elderly especially need to pay attention to. The virus spreads through droplets, when an infected person coughs or sneezes, the virus will be spread to nearby people through droplets in the air; in addition, it may also be spread through contact with surfaces contaminated with the virus, which can rapidly cause a large number of cases.
Clinical symptoms are: high fever, cough, sore throat, nasal congestion and muscle pain.
Protection against dengue virus
The Southwest, with its warm climate and high humidity, is prone to dengue virus, mainly through mosquito bites, and its vectors are the Aedes aegypti and Aedes albopictus mosquitoes, which are active during the daytime, especially in the early morning and at dusk, so groups that are often plagued by mosquito bites need to pay attention to it.
After infection, the virus spreads quickly and painfully, and the clinical symptoms are: high fever, headache, eye pain, joint and muscle pain, rash, bleeding tendency.
Therefore, rapid diagnosis has a very important clinical value, which is conducive to the timely completion of the diagnosis of the disease, to take therapeutic measures to reduce the harm of the disease on the patient.
Interpretation sharing: high viral prevalence and timely diagnosis by molecular diagnostic techniques.
Molecular diagnostic technology: timely stalking of viruses
In this invisible war, molecular diagnostic technology is like a sharp sword.
Traditional diagnostic methods require about 2H, while the nucleic acid thermostatic rapid test technology is shortened to 40min, and the MIRA technology (Multi-enzymatic Rapid Nucleic Acid Amplification) is even shorter than 5-20min, which makes us able to make an accurate diagnosis in the shortest possible time after the invasion of the virus.
MIRA technology rapid test, rapid protection of life and health
AmpFuture's Multi-Enzyme Rapid Amplification of Nucleic Acids (MIRA technology) can amplify nucleic acids at a constant temperature of 39°C-42°C, which can be completed quickly in 20min, and the sensitivity can reach the same level as PCR.
In addition, MIRA technology does not rely on complex equipment, and can be operated on-site in non-laboratory environments and primary healthcare units, making it simple, convenient and quick to diagnose.
Diversified forms of reagent products: liquid, lyophilized, microspheres, etc.; Diversity of display results: gel electrophoresis, fluorescence curves, colloidal gold test strips, etc.; Stable performance, easy to operate, convenient for storage and transportation.
At the same time, with MIRA as the core platform technology, we have developed a series of ancillary products, such as "Ultra-fast Nucleic Acid Release Technology", "Dual-channel Constant Temperature Fluorescence Detector", "Integrated Fully-automatic Closed Detection System", "Self-detection Nucleic Acid Detection Device" and ", and are striving to create a total solution for the field of rapid molecular detection.
Amp-Future Bio provides professional products and technical services, and has established deep cooperative relationships with a number of institutions of higher learning and scientific research units, more and more projects and scientific research articles to meet with you, and better contribute to the guardianship of life and health.
Let's take a look at China's grandest clinical testing expo
From March 16th to 18th, 2024, the CACLP THE 21st China Association of Clinical Laboratory Practice Expo was held in China. This expo is the grandest gathering in the Chinese in vitro diagnostics industry, bringing together more than 1,300 in vitro diagnostic companies and many renowned industry experts and professors who attended related conferences.
Amp Future participated in this grand event with its patented technology - MIRA (Multienzyme Isothermal Rapid Amplification), showcasing onsite rapid test reagent kits and compact testing devices. Compared to PCR technology, MIRA is more suited for molecular POCT applications, offering significant advantages in medical system laboratories, rapid testing scenarios for infectious diseases, accurately detecting respiratory, reproductive diseases, pathogens, etc., with a detection limit as low as 1-5 copies/μl. It also demonstrates simplicity and efficiency in applications such as on-site breeding and planting, pet testing, and meat source detection, speeding up testing and screening efforts.
We welcome you to contact us to learn more about MIRA, representing the future of nucleic acid rapid testing technology, and join us in advancing the development of disease detection.
World TB Day，Amp Future is working on it！
March 24 is World TB Day, and this year's theme is "Together, you and I, to End the TB epidemic."
Tuberculosis (TB) is a chronic respiratory infectious disease caused by Mycobacterium tuberculosis, which is seriously harmful to health. TB is often spread through respiratory droplets and close contact. There is no strong vaccine for TB, and prevention and detection are key.
Due to the relatively backward economic development of some countries or regions and the lack of medical resources, general screening can not be close to patients, resulting in tuberculosis detection and other difficulties.
Epu Future Biology provides a set of solutions for primary care and field rapid inspection.
Using MIRA rapid nucleic acid amplification technology as a platform, nucleic acid extraction can be completed in 5min, and nucleic acid amplification can be completed in 20min, which greatly improves the screening efficiency.
With small testing equipment, no need for professional laboratories, when the disease occurs, directly carry the bag to the first line for quick inspection.
Freeze-dried reagent, room temperature storage and transportation, simple operation, flexible to field testing.
Unlock new products! Pocket detection guardian
Rapid and simple, accurate and convenient, anytime and anywhere, ready to use and throw away...
The combination of these words that are practical and convenient for end customers is the new product launched by Amp- future Biotech - Pocket Detection Guardian.
Based on MIRA multienzyme isothermal nucleic acid rapid amplification technology, Amp- future Biotech has developed a small self-detection device that can be used in households, breeding and planting, pets and other scenarios. Personnel without professional background can complete the detetcion by themselves through simple training. The sensitivity reaches 1-5 copies/μL, which is the same level as PCR.
Home self-detection. Can be used for regular monitoring of diseases. The elderly and children who are inconvenient to travel can complete the detection at home, while also protecting the patient's privacy.
On-site detection of breeding and planting. Whether it is a large animal breeding farm or an agricultural field, the Pocket Testing Guardian is equipped with a power bank to conduct detection in a non-laboratory environment, speeding up the efficiency of front-line screening and reducing economic losses in the breeding and planting industry.
Pet disease detection. In a home environment, the Pocket Testing Guardian can help pets complete disease detection without going out, which is convenient and rapid. It can also speed up the detection efficiency of pet hospitals and increase the carrying capacity of detection services.
